Haematological adverse events associated with tyrosine kinase inhibitors in chronic myeloid leukaemia: A network meta‐analysis

AIMS: Despite their overall favourable safety profile, tyrosine kinase inhibitors (TKIs) are related to severe adverse events including haematological toxicities such as anaemia, leucopenia, neutropenia and thrombocytopenia. We designed a systematic review and network meta‐analysis of randomised con...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Fachi, Mariana M., Tonin, Fernanda S., Leonart, Leticia P., Rotta, Inajara, Fernandez‐Llimos, Fernando, Pontarolo, Roberto
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6783623/
https://ncbi.nlm.nih.gov/pubmed/30907446
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13933
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados